MG

Manju Goyal

Active Director Director DIN 09584012
DIN 09584012 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Manju Goyal

Data last updated:

Manju Goyal is a Director at Oxoniq Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Oxoniq Pharmaceuticals Private Limited reported revenue of ₹10.1 Lakh (FY 2025).

DIN 09584012
Primary Designation Director
Industry Chemicals
First Appointment 02 Apr 2022
Oldest Company Age 4 yrs
Largest company Oxoniq Pharmaceuticals Private Limited · ₹10.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Apr 20222021₹10.1 Lakh (FY 2025)Active

Board colleagues of Manju Goyal

NameDINCompanyDesignation
Yadav Goyal08995159Oxoniq Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oxoniq Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manju Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Goyal

Manju Goyal currently holds 1 directorship: Oxoniq Pharmaceuticals Private Limited (Director, since 02 Apr 2022, revenue ₹10.1 Lakh (FY 2025)).

Manju Goyal was first appointed on 02 Apr 2022 as Director at Oxoniq Pharmaceuticals Private Limited.

The current boards of Manju Goyal's companies include Yadav Goyal (Oxoniq Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available